7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 7 of 7 clinical reviews.
A detailed review of ethnicity-stratified trial data, pharmacogenomic differences, and clinical considerations for prescribing Saxenda (liraglutide 3 mg) in Black and African ancestry patients.
A clinical deep-dive into liraglutide 3 mg (Saxenda) dose adjustments, pharmacogenomics, efficacy, and safety considerations specific to Black and African ancestry patients, with ethnicity-stratified trial data and guideline references.
A clinical deep-dive into how liraglutide 3 mg (Saxenda) performs in East Asian patients, covering ethnicity-stratified trial subgroups, pharmacogenomic differences, BMI thresholds, and dosing considerations reviewed by the HealthRX.com medical team.
Evidence-based review of how Saxenda (liraglutide 3 mg) safety and pharmacogenomics differ in East Asian populations, including dosing considerations, BMI thresholds, and adverse event profiles.
A clinician-reviewed guide to liraglutide 3 mg dosing in Hispanic and Latino patients, covering ethnicity-stratified trial data, pharmacogenomics, insulin-resistance phenotypes, and practical titration protocols.
Evidence review of liraglutide 3 mg (Saxenda) efficacy in South Asian populations, covering ethnicity-stratified trial data, lower BMI thresholds, pharmacogenomics, and dosing considerations.
Evidence-based guide to Saxenda (liraglutide 3 mg) dose adjustments for South Asian patients, covering pharmacogenomics, lower BMI thresholds, and clinical trial subgroup data.